0001193125-23-084462.txt : 20230330 0001193125-23-084462.hdr.sgml : 20230330 20230330064352 ACCESSION NUMBER: 0001193125-23-084462 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230330 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230330 DATE AS OF CHANGE: 20230330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oak Street Health, Inc. CENTRAL INDEX KEY: 0001564406 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 843446686 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39427 FILM NUMBER: 23777080 BUSINESS ADDRESS: STREET 1: 30 W. MONROE ST., STE. 1200 CITY: CHICAGO STATE: IL ZIP: 60603 BUSINESS PHONE: 312-773-3374 MAIL ADDRESS: STREET 1: 30 W. MONROE ST., STE. 1200 CITY: CHICAGO STATE: IL ZIP: 60603 FORMER COMPANY: FORMER CONFORMED NAME: Oak Street Health, LLC DATE OF NAME CHANGE: 20121211 8-K 1 d533000d8k.htm 8-K 8-K
false 0001564406 0001564406 2023-03-30 2023-03-30

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 30, 2023

 

 

Oak Street Health, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware
   001-39427
   84-3446686
(State or other jurisdiction
of incorporation)		  

(Commission

File Number)

   (IRS Employer
Identification No.)

30 W. Monroe Street
Suite 1200

Chicago, Illinois 60603

(Address of principal executive offices)

(844) 871-5650

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☒

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange
on which registered

Common Stock, $0.001 par value   OSH   The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 8.01

Other Events.

On March 30, 2023, Oak Street Health, Inc., a Delaware corporation (“Oak Street Health”), issued a press release, a copy of which is furnished as Exhibit 99.1 and incorporated by reference into this Item 8.01, announcing that Oak Street Health’s Board of Directors has cancelled its 2023 Annual Meeting of Stockholders previously scheduled for April 27, 2023, at 8:30 A.M., Central Time.

Cautionary Statement Regarding Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of Oak Street Health. This Current Report on Form 8-K contains forward-looking statements, which include all statements that do not relate solely to historical or current facts, such as statements regarding Oak Street Health’s expectations, intentions or strategies regarding the future. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “aim,” “potential,” “continue,” “ongoing,” “goal,” “can,” “seek,” “target” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. Statements in this Current Report on Form 8-K that are forward looking may include, but are not limited to, statements regarding the expected timing of the closing of the proposed acquisition and other transactions contemplated by the merger agreement governing the proposed transaction (the “Merger Agreement”). By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Such risks and uncertainties include, but are not limited to: the occurrence of any event, change or other circumstance that could give rise to the right of Oak Street Health or CVS Health Corporation (“CVS Health”) or both of them to terminate the Merger Agreement, including circumstances requiring a party to pay the other party a termination fee pursuant to the Merger Agreement; the failure to obtain Oak Street Health stockholder approval in a timely manner or otherwise; the risk that the acquisition may not close in the anticipated timeframe or at all due to one or more of the other closing conditions to the transaction not being satisfied or waived; the risk that there may be unexpected costs, charges or expenses resulting from the proposed acquisition; risks that the proposed transaction disrupts Oak Street Health’s current plans and operations; the risk that certain restrictions during the pendency of the proposed transaction may impact Oak Street Health’s ability to pursue certain business opportunities or strategic transactions; risks related to disruption of each company’s management’s time and attention from ongoing business operations due to the proposed transaction; continued availability of capital and financing and rating agency actions; the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of Oak Street Health’s common stock, credit ratings or operating results; the risk that the proposed transaction and its announcement could have an adverse effect on the ability of Oak Street Health to retain and hire key personnel, to retain customers and to maintain relationships with its business partners, suppliers and customers and on its operating results and businesses generally, including with respect to Humana Inc. and its affiliates, which lease or license to Oak Street Health a majority of Oak Street Health’s primary care centers; the risk of litigation that could be instituted against the parties to the Merger Agreement or their respective directors, managers or officers and/or regulatory actions related to the proposed acquisition, including the effects of any outcomes related thereto; risks related to unpredictable and severe or catastrophic events, including but not limited to acts of terrorism, war or hostilities, cyber attacks, or the impact of the COVID-19 pandemic or any other pandemic, epidemic or outbreak of an infectious disease in the United States or worldwide on Oak Street Health’s business, financial condition and results of operations, as well as the response thereto by each company’s management; and other business effects, including the effects of industry, market, economic, political or regulatory conditions. Also, Oak Street Health’s actual results may differ materially from those contemplated by the forward-looking statements for a number of additional reasons as described in Oak Street Health’s filings with the Securities and Exchange Commission (the “SEC”), including those set forth in the Risk Factors section and under any “Forward-Looking Statements” or similar heading in Oak Street Health’s most recently filed Annual Report on Form 10-K and Oak Street Health’s Current Reports on Form 8-K.

You are cautioned not to place undue reliance on Oak Street Health’s forward-looking statements. Oak Street Health’s forward-looking statements are and will be based upon management’s then-current views and assumptions regarding CVS Health’s proposed acquisition of Oak Street Health, future events and operating performance, and are applicable only as of the dates of such statements. Oak Street Health assumes no duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.

 

 

2

Additional Information and Where to Find It

This communication is being made in respect of the proposed transaction involving Oak Street Health and CVS Health. Oak Street Health has filed a definitive proxy statement and a form of proxy card with the SEC in connection with the solicitation of proxies for the special meeting of stockholders of Oak Street Health relating to the proposed transaction (the “Definitive Proxy Statement”). This Current Report on Form 8-K is not a substitute for the Definitive Proxy Statement or any other document that may be filed by Oak Street Health with the SEC.

BEFORE MAKING ANY DECISION, OAK STREET HEALTH STOCKHOLDERS ARE URGED TO CAREFULLY READ THE DEFINITIVE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION OR INCORPORATED BY REFERENCE INTO THE DEFINITIVE PROXY STATEMENT BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.

Any vote in respect of resolutions to be proposed at Oak Street Health’s special meeting of stockholders to approve the proposed transaction or other responses in relation to the proposed transaction should be made only on the basis of the information contained in the Definitive Proxy Statement. You may obtain a free copy of the Definitive Proxy Statement and other related documents filed by Oak Street Health and documents filed by CVS Health with the SEC at the website maintained by the SEC at www.sec.gov or by accessing the Investor Relations section of Oak Street Health’s website at https://www.oakstreethealth.com for documents filed by Oak Street Health or the Investors portion of CVS Health’s website at https://investors.cvshealth.com for documents filed by CVS Health.

No Offer or Solicitation

This communication is for information purposes only and is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Participants in the Solicitation

Oak Street Health, CVS Health and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from Oak Street Health’s stockholders in connection with the proposed transaction. Information regarding CVS Health’s directors and executive officers is contained in CVS Health’s Definitive Proxy Statement for its 2022 Annual Meeting of Stockholders filed with the SEC on April 1, 2022, as updated by CVS Health’s subsequent filings made on www.sec.gov. Information regarding Oak Street Health’s directors and executive officers, including a description of their respective direct or indirect interests, by security holdings or otherwise, is and will be included in the Definitive Proxy Statement and Oak Street Health’s other filings with the SEC made subsequent to the date of the Definitive Proxy Statement. To the extent holdings of Oak Street Health’s securities by such directors or officers have changed or will change since the amounts printed as of a date disclosed in the Definitive Proxy Statement, such changes have been or will be reflected on Initial Statements of Beneficial Ownership on Form 3, Statements of Changes in Beneficial Ownership on Form 4 or other ownership reports filed with the SEC. Additional information regarding the identity of potential participants, and their direct or indirect interests, by security holdings or otherwise, is set forth in the Definitive Proxy Statement and other materials to be filed with the SEC in connection with the special meeting of Oak Street Health’s stockholders. These documents can be obtained free of charge from the SEC’s website at www.sec.gov or by accessing the Investor Relations section of Oak Street Health’s website at https://www.oakstreethealth.com for documents filed by Oak Street Health or the Investors portion of CVS Health’s website at https://investors.cvshealth.com for documents filed by CVS Health.

 

 

3

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit Number   

Description

99.1    Press Release, issued on March 30, 2023.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

4

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  OAK STREET HEALTH, INC.
Date: March 30, 2023     By:  

/s/ Robert Guenthner

      Name: Robert Guenthner
      Title: Chief Legal Officer
 EX-99.1 2 d533000dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Oak Street Health Announces Cancellation of its 2023 Annual Meeting of Stockholders

CHICAGO – (BUSINESS WIRE) – Oak Street Health, Inc. (NYSE: OSH or “Oak Street Health”), a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, today announced its Board of Directors has cancelled its 2023 Annual Meeting of Stockholders scheduled for Thursday, April 27, 2023, at 8:30 A.M., Central Time (the “Annual Meeting”).

This follows the previously announced definitive agreement under which CVS Health Corporation (NYSE: CVS or “CVS Health”), a leading health solutions company, will acquire Oak Street Health in an all-cash transaction at $39.00 per share, representing an enterprise value of approximately $10.6 billion. Oak Street Health currently anticipates that the transaction will close in the first half of 2023, subject to customary closing conditions, including approval of the merger by Oak Street Health stockholders. Oak Street Health expects that the current members of its Board of Directors will continue as directors until the closing of the transaction. Upon closing of the transaction, Oak Street Health common stock will no longer be listed on any public market.

If the transaction is not completed pursuant to the terms of the merger agreement governing the proposed transaction (the “Merger Agreement”), the Oak Street Health Board of Directors will reschedule the Annual Meeting for a later date.

About Oak Street Health, Inc.

Founded in 2012, Oak Street Health is a network of value-based primary care centers for adults on Medicare. With a mission of rebuilding healthcare as it should be, Oak Street Health operates an innovative healthcare model focused on quality of care over volume of services and assumes the full financial risk of its patients. Oak Street Health currently operates more than 170 centers across 21 states and is the only primary care provider to carry the AARP name. Oak Street Health is a winner of Energage’s 2022 Top Workplaces USA award, was recognized by Inc. on its inaugural Best-Led Companies of 2021 list and was honored as a recipient of the 2022 and 2021 Joy in Medicine™ Health System Recognition Program by the American Medical Association. To learn more about Oak Street Health’s proven approach to care, visit oakstreethealth.com.

Cautionary Statement Regarding Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of Oak Street Health. This press release contains forward-looking statements, which include all statements that do not relate solely to historical or current facts, such as statements regarding Oak Street Health’s expectations, intentions or strategies regarding the future. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “aim,” “potential,” “continue,” “ongoing,” “goal,” “can,” “seek,” “target” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. Statements in this press release that are forward looking may include, but are not limited to, statements regarding the expected timing of the closing of the proposed acquisition and other transactions contemplated by the Merger Agreement. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Such risks and uncertainties include, but are not limited to: the occurrence of any event, change or other circumstance that could give rise to the right of Oak Street Health or CVS Health or both of them to terminate the Merger Agreement, including circumstances requiring a party to pay the other party a termination fee pursuant to the Merger Agreement; the failure to obtain Oak Street Health stockholder approval in a timely manner or otherwise; the risk that the acquisition may not close in the anticipated timeframe or at all due to one or more of the other closing conditions to the transaction not being satisfied or waived; the risk that there may be unexpected costs, charges or expenses resulting from the proposed acquisition; risks that the proposed transaction disrupts Oak Street Health’s current plans and operations; the risk that certain restrictions during the pendency of the proposed transaction may impact Oak Street Health’s ability to pursue certain business opportunities or strategic transactions; risks related to disruption of each company’s management’s time and attention from ongoing business operations due to the proposed transaction; continued availability of capital and financing and rating agency actions; the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of Oak Street Health’s common stock, credit ratings or operating results; the risk that the proposed transaction and its

announcement could have an adverse effect on the ability of Oak Street Health to retain and hire key personnel, to retain customers and to maintain relationships with its business partners, suppliers and customers and on its operating results and businesses generally, including with respect to Humana Inc. and its affiliates, which lease or license to Oak Street Health a majority of Oak Street Health’s primary care centers; the risk of litigation that could be instituted against the parties to the Merger Agreement or their respective directors, managers or officers and/or regulatory actions related to the proposed acquisition, including the effects of any outcomes related thereto; risks related to unpredictable and severe or catastrophic events, including but not limited to acts of terrorism, war or hostilities, cyber attacks, or the impact of the COVID-19 pandemic or any other pandemic, epidemic or outbreak of an infectious disease in the United States or worldwide on Oak Street Health’s business, financial condition and results of operations, as well as the response thereto by each company’s management; and other business effects, including the effects of industry, market, economic, political or regulatory conditions. Also, Oak Street Health’s actual results may differ materially from those contemplated by the forward-looking statements for a number of additional reasons as described in Oak Street Health’s filings with the Securities and Exchange Commission (the “SEC”), including those set forth in the Risk Factors section and under any “Forward-Looking Statements” or similar heading in Oak Street Health’s most recently filed Annual Report on Form 10-K and Oak Street Health’s Current Reports on Form 8-K.

You are cautioned not to place undue reliance on Oak Street Health’s forward-looking statements. Oak Street Health’s forward-looking statements are and will be based upon management’s then-current views and assumptions regarding CVS Health’s proposed acquisition of Oak Street Health, future events and operating performance, and are applicable only as of the dates of such statements. Oak Street Health assumes no duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.

Additional Information and Where to Find It

This press release is being made in respect of the proposed transaction involving Oak Street Health and CVS Health. Oak Street Health has filed a definitive proxy statement and a form of proxy card with the SEC in connection with the solicitation of proxies for the special meeting of stockholders of Oak Street Health relating to the proposed transaction (the “Definitive Proxy Statement”). This press release is not a substitute for the Definitive Proxy Statement or any other document that may be filed by Oak Street Health with the SEC.

BEFORE MAKING ANY DECISION, OAK STREET HEALTH STOCKHOLDERS ARE URGED TO CAREFULLY READ THE DEFINITIVE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION OR INCORPORATED BY REFERENCE INTO THE DEFINITIVE PROXY STATEMENT BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.

Any vote in respect of resolutions to be proposed at Oak Street Health’s special meeting of stockholders to approve the proposed transaction or other responses in relation to the proposed transaction should be made only on the basis of the information contained in the Definitive Proxy Statement. You may obtain a free copy of the Definitive Proxy Statement and other related documents filed by Oak Street Health and documents filed by CVS Health with the SEC at the website maintained by the SEC at www.sec.gov or by accessing the Investor Relations section of Oak Street Health’s website at https://www.oakstreethealth.com for documents filed by Oak Street Health or the Investors portion of CVS Health’s website at https://investors.cvshealth.com for documents filed by CVS Health.

No Offer or Solicitation

This press release is for information purposes only and is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Participants in the Solicitation

Oak Street Health, CVS Health and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from Oak Street Health’s stockholders in connection with the proposed transaction. Information regarding CVS Health’s directors and executive officers is contained in CVS Health’s Definitive Proxy Statement for its 2022 Annual Meeting of Stockholders filed with the SEC on April 1, 2022, as updated by CVS Health’s subsequent filings made on www.sec.gov. Information regarding Oak Street Health’s directors and executive officers, including a description of their respective direct or indirect interests, by security holdings or otherwise, is and will be included in the Definitive Proxy Statement and Oak Street Health’s other filings with the SEC made subsequent to the date of the Definitive Proxy Statement. To the extent holdings of Oak Street Health’s securities by such directors or officers have changed or will change since the amounts printed as of a date disclosed in the Definitive Proxy Statement, such changes have been or will be reflected on Initial Statements of Beneficial Ownership on Form 3, Statements of Changes in Beneficial Ownership on Form 4 or other ownership reports filed with the SEC. Additional information regarding the identity of potential participants, and their direct or indirect interests, by security holdings or otherwise, is set forth in the Definitive Proxy Statement and other materials to be filed with the SEC in connection with the special meeting of Oak Street Health’s stockholders. These documents can be obtained free of charge from the SEC’s website at www.sec.gov or by accessing the Investor Relations section of Oak Street Health’s website at https://www.oakstreethealth.com for documents filed by Oak Street Health or the Investors portion of CVS Health’s website at https://investors.cvshealth.com for documents filed by CVS Health.

Contact Information:

Media:

Erica Frank

Vice President of Public Relations

(330) 990-5026

erica.frank@oakstreethealth.com

Investors:

Sarah Cluck

Head of Investor Relations

(773) 572-0254

sarah.cluck@oakstreethealth.com

EX-101.SCH 3 osh-20230330.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 osh-20230330_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, Address Line Three Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 5 osh-20230330_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information
Mar. 30, 2023
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001564406
Document Type 8-K
Document Period End Date Mar. 30, 2023
Entity Registrant Name Oak Street Health, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-39427
Entity Tax Identification Number 84-3446686
Entity Address, Address Line One 30 W. Monroe
Entity Address, Address Line Two Street
Entity Address, Address Line Three Suite 1200
Entity Address, City or Town Chicago
Entity Address, State or Province IL
Entity Address, Postal Zip Code 60603
City Area Code (844)
Local Phone Number 871-5650
Written Communications false
Soliciting Material true
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.001 par value
Trading Symbol OSH
Security Exchange Name NYSE
Entity Emerging Growth Company false
XML 7 d533000d8k_htm.xml IDEA: XBRL DOCUMENT 0001564406 2023-03-30 2023-03-30 false 0001564406 8-K 2023-03-30 Oak Street Health, Inc. DE 001-39427 84-3446686 30 W. Monroe Street Suite 1200 Chicago IL 60603 (844) 871-5650 false true false false Common Stock, $0.001 par value OSH NYSE false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d533000d8k.htm d533000dex991.htm osh-20230330.xsd osh-20230330_lab.xml osh-20230330_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d533000d8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 24 }, "contextCount": 1, "dts": { "inline": { "local": [ "d533000d8k.htm" ] }, "labelLink": { "local": [ "osh-20230330_lab.xml" ] }, "presentationLink": { "local": [ "osh-20230330_pre.xml" ] }, "schema": { "local": [ "osh-20230330.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "osh", "nsuri": "http://www.oakstreethealth.com/20230330", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d533000d8k.htm", "contextRef": "duration_2023-03-30_to_2023-03-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d533000d8k.htm", "contextRef": "duration_2023-03-30_to_2023-03-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oakstreethealth.com//20230330/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001193125-23-084462-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-084462-xbrl.zip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